Tumor Marker Testing Market Research Report and Forecast up to 2024 Tumor Marker Testing Market - Global Industry Anal
Tumor Marker Testing Market - Global Industry
Analysis, Size, Share, Growth, Trends, and
Forecast 2016 - 2024
A biomarker is any cellular, physical, chemical, or molecular change that can be
noted and a normal or abnormal process in human body can be studied. The effects
of treatment, the presence, progress or risk for a disease can be checked by
studying any alteration in the normal amount of a biomarker. A tumor marker, like a
biomarker, is a naturally occurring substance in the body. An increased quantity of a
tumor marker can show the presence of a cancer. Some tumor markers are related
to several different types of cancer, while some are specific to one type of cancer.
Tumor markers may also increase with non-cancerous conditions. A tumor marker
can be prepared by cancer cells or by the body in response to cancer.
View
Report
@
http://www.transparencymarketresearch.com/tumor-
marker-testing-market.html
There are many different types of tumor markers such as human chorionic
gonadotropin (HCG or b-HCG), cancer antigen 15-3 (CA15-3), alpha-fetoprotein
(AFP), carbohydrate antigen 19-9 (CA19-9), cancer antigen 125 (CA125),
carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA). Tumor
markers can provide information that can be used for screening for cancer,
diagnose cancer, determine stage of cancer, determine a person’s prognosis, guide
treatment, monitor treatment, and determine recurrence of the cancer. Some
markers can be used in people with family history of a particular cancer. Prostate
specific antigen can be used to screen for prostate cancer. Tumor markers can be
used to help determine how far the cancer has spread into other tissues or organs.
Some markers are used to determine how aggressive a cancer is likely to be. Some
markers may help doctors predict what treatments the cancer is likely to respond to.
A tumor marker test is done to make available a baseline level before treatment,
when any type of cancer is suspected, to check if cancer has returned after
treatment being given, and to check a person’s reaction to cancer treatment. Tumor
markers are molecules found in urine, blood, and body tissues. It is a protein found
in large amounts in presence of cancer. Hence, measuring the levels of tumor
markers may help in detecting the presence of cancer. Presence of a tumor in body
stimulates the production of tumor markers from tumor or non-tumor cells. The
tumor marker testing market has been categorized based on diagnostic method,
type of cancer, and technology employed for cancer detection. Organ specific tumor
marker: bladder, breast, colorectal, gastrointestinal, liver, lung, oral, ovarian,